Finch Therapeutics lands $36 mln Series B

Somerville, Massachusetts-based Finch Therapeutics, a microbiome therapeutics company, has raised $36 million in Series B financing. The investors included Shumway Capital, Willett Advisors, Morgan Noble and Avenir Growth Capital.

Source: Press Release